Neuronoff's Injectrode Platform Advances Neuromodulation Techniques Beyond Spinal Applications Neuronoff, Inc. showcases its Injectrode platform, enabling multi-target nerve stimulation without complex surgery, advancing neuromodulation therapies significantly.

Neuronoff's Injectrode Platform Advances Neuromodulation Techniques Beyond Spinal Applications #USA #Cleveland #Neuromodulation #Neuronoff #Injectrode

Neuronoff Secures $4.5M Funding for Innovative Chronic Pain Injection Platform Neuronoff, Inc. has successfully closed a $4.5 million funding round, paving the way for its Injectrode platform aimed at chronic pain treatment without surgery.

Neuronoff Secures $4.5M Funding for Innovative Chronic Pain Injection Platform #United_States #Cleveland #Chronic_Pain #Neuronoff #Injectrode

Neuronoff Breaks New Ground with $5 Million Funding for Innovative Neuromodulation Research Neuronoff, Inc. has secured $5 million in funding from the DOD and NIH to enhance its Injectrode technology for minimally invasive neuromodulation treatments, targeting conditions like overactive bladder and neurogenic bladder.

Neuronoff Breaks New Ground with $5 Million Funding for Innovative Neuromodulation Research #United_States #Cleveland #Neuromodulation #Neuronoff #Injectrode